Condition (MeSH)
Phlebitis
ClinicalTrials.gov lists 59 trials for Phlebitis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
43 of the 59 trials are tagged with Phlebitis itself; the rest are tagged with a narrower condition beneath it.
When did Phlebitis trials start? (23)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 5 |
| 2024 | 2 |
| 2023 | 7 |
| 2022 | 6 |
| 2021 | 4 |
| 2020 | 3 |
| 2019 | 1 |
| 2018 | 1 |
| 2017 | 1 |
Showing 10 of 23 earlier years.
No forecast is made for this condition: it averages 4.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Phlebitis trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 1 |
| Phase 2/3 | 1 |
| Phase 3 | 10 |
| Phase 4 | 4 |
| Not applicable | 33 |
| Observational | 8 |
How many Phlebitis trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Completed | 38 |
| Suspended | 1 |
| Terminated | 3 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Phlebitis? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Sesame Oil | 2 |
| Aloe Vera Gel | 1 |
| (LMW)heparin | 1 |
Interventions as named in the registry (12)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Nitroglycerin Ointment | 2 |
| Warfarin VKA | 2 |
| Recombinant Tissue Plasminogen Activator | 2 |
| Fragmin P Forte (dalteparin sodium) | 2 |
| LMWH parnaparin subcutaneously | 1 |
Showing 5 of 12 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Phlebitis trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| death | 822 | 1 |
| cardiovascular | 310 | 1 |
| cancer | 182 | 1 |
| haemorrhage | 135 | 1 |
| Pulmonary Embolism (PE) | 122 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Phlebitis? (85)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| The effect of cold gel pack application in the prevention of amiodarone-related phlebitis. | Nursing in critical care | 2024 | Yes |
| Evaluation of the effect of proximal massage and palm fisting in reducing the risk of peripheral venous catheter-related phlebitis: randomized control study. | European journal of cardiovascular nursing | 2024 | Yes |
| Evaluation of chemotherapy infusion and phlebitis among cancer patients: A prospective observational single-center study. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023 | Yes |
| A meta-analysis of the comparison of phlebitis between midline catheters and peripherally inserted central catheters in infusion therapy. | International journal of nursing practice | 2022 | Yes |
| Peripheral intravenous catheter failure: A secondary analysis of risks from 11,830 catheters. | International journal of nursing studies | 2021 | Yes |
Showing 5 of 85 publications.
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, and rare-disease identity.